GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Fox Corporation Reports $5.18 Billion Revenue and $247 Million Net Income for Q2 Fiscal 2026

by GOAI
Share To

Fox Corporation reported its financial results for the second quarter of fiscal year 2026, revealing revenues of $5.18 billion, a net income of $247 million, and an adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $692 million. These figures reflect the company’s performance during the three-month period ending December 31, 2025.

The revenue figure represents total earnings generated across Fox’s various business segments during the quarter. The reported net income indicates the company’s profit after accounting for all expenses, taxes, and costs. Adjusted EBITDA provides a measure of operational profitability by excluding certain non-operational factors such as interest payments and depreciation costs. Further details on how these numbers compare to previous quarters or years were not disclosed in this report.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Lilly Acquires Orna Therapeutics in $2.4B to Scale In Vivo CAR-T Cell Therapies
2026-02-10
CCHH Receives Nasdaq Notice for Falling Below $1.00 Minimum Bid Price
2026-02-10
South African Patent Office Grants Manganese X Energy Corp. Patent for High-Purity Manganese Processing Technology
2026-02-10
Study Explores Impact of Symptoms on Health-Related Quality of Life in Older Swedish Men
2026-02-10
Study Finds Gaps in Support Systems for Parents Using At-Home Medical Devices for Children with Complex Needs
2026-02-10
Radiopharmaceutical Industry Faces Talent Shortage Amid Rapid Expansion
2026-02-10
FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top